We are delighted to share that Cygames Inc. has once again extended their generous support to us, building upon their previous year's contribution. On this occasion, we wish to convey our deep and heartfelt gratitude to Cygames Inc. The entire team at the research institute is wholeheartedly dedicated to advancing our efforts, aiming to finalize the development of AIM-based medication that holds the potential to revolutionize the treatment of both feline and human illnesses. Our utmost priority is to expedite the delivery of this groundbreaking solution to you, fulfilling the expectations you have kindly placed in us. We genuinely value your enduring support for IAM.
Warm regards,

Toru Miyazaki Director and President, IAM